v3 Template
B

bioAffinity Technologies

Healthcare/Biotechnology San Antonio, Texas ~460 employees
Founded
--
Employees (Est.)
~460
23 leaders known
Total Funding
$50.0M
Funding Rounds
23
Last Funding
2025-10-09

About bioAffinity Technologies

bioAffinity Technologies focuses on addressing the urgent need for noninvasive, early-stage cancer diagnosis and targeted cancer treatment. Their mission is to detect and treat cancer at the cellular level, with an emphasis on early detection to save lives, particularly for lung cancer, which is the leading cause of cancer-related deaths.

Products & Services

CyPath® Lung:A noninvasive test for early-stage lung cancer diagnosis using advanced flow cytometry to analyze sputum and detect cancer-indicative cell populations. It assists clinical decision-making for patients with suspicious findings on low-dose computed tomography (LDCT), offering high sensitivity (92%) and specificity (87%) for high-risk individuals with nodules less than 20 mm. Sold by Precision Pathology Laboratory Services as a Laboratory Developed Test (LDT).

Specialties

Early-stage cancer diagnosis Noninvasive testing Lung cancer detection Flow cytometry Targeted cancer treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering 		A: 1800000
MR: -
FA: $1.8M
FAN: 1800000 		D: 2025-10-09
FD: 2025-10-09 		1 investors
2 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering 		A: 1800000
MR: -
FA: approximately $1.8 million
FAN: 1800000 		D: 2025-10-08
FD: 2025-10-08 		1 investors
3 RT: Public Offering
T: -
FT: Public Offering 		A: 4800000
MR: -
FA: 4.8 million
FAN: 4800000 		D: 2025-09-30
FD: 2025-09-30 		-
4 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering 		A: 1800000
MR: -
FA: 1.8 million
FAN: 1800000 		D: 2025-09-30
FD: 2025-09-30 		-
5 RT: Public Offering
T: -
FT: Public Offering 		A: 4800000
MR: -
FA: 4.8 million
FAN: 4800000 		D: 2025-09-29
FD: 2025-09-29 		-
6 RT: Private Placement and Warrant Inducement Transaction
T: -
FT: Private Placement and Warrant Inducement Transaction 		A: 1200000
MR: -
FA: $1.2 Million
FAN: 1200000 		D: 2025-08-14
FD: 2025-08-14 		1 investors
7 RT: Private Placement and Warrant Inducement
T: -
FT: Private Placement and Warrant Inducement 		A: 1200000
MR: -
FA: Approximately $1.2 Million
FAN: 1200000 		D: 2025-08-14
FD: 2025-08-14 		-
8 RT: Private Placement
T: -
FT: Private Placement 		A: 1200000
MR: -
FA: approximately $1.2 million
FAN: 1200000 		D: 2025-08-13
FD: 2025-08-13 		2 investors
9 RT: Private Placement and Warrant Inducement
T: -
FT: Private Placement and Warrant Inducement 		A: 1200000
MR: -
FA: $1.2 million
FAN: 1200000 		D: 2025-08-13
FD: 2025-08-13 		2 investors
10 RT: Public Offering
T: -
FT: Public Offering 		A: 3250000
MR: -
FA: $3.25 million
FAN: 3250000 		D: 2025-05-07
FD: 2025-05-07 		1 investors
11 RT: Best Efforts Offering
T: -
FT: Best Efforts Offering 		A: 3250000
MR: -
FA: $3.25 million
FAN: 3250000 		D: 2025-05-06
FD: 2025-05-06 		-
12 RT: Warrant Inducement
T: -
FT: Warrant Inducement 		A: 1400000
MR: -
FA: approximately $1.4 million
FAN: 1400000 		D: 2025-02-26
FD: 2025-02-26 		2 investors
13 RT: Warrant Inducement Transaction
T: -
FT: Warrant Inducement Transaction 		A: 1400000
MR: -
FA: $1.4 million
FAN: 1400000 		D: 2025-02-26
FD: 2025-02-26 		1 investors
14 RT: Warrant Inducement
T: -
FT: Warrant Inducement 		A: 1400000
MR: -
FA: $1.4 million
FAN: 1400000 		D: 2025-02-25
FD: 2025-02-25 		1 investors
15 RT: Warrant Inducement / Private Placement
T: -
FT: Warrant Inducement / Private Placement 		A: 1400000
MR: -
FA: approximately $1.4 million
FAN: 1400000 		D: 2025-02-25
FD: 2025-02-25 		1 investors
16 RT: Registered Direct Offering and Private Placement
T: -
FT: Registered Direct Offering and Private Placement 		A: 2662782
MR: -
FA: $2,662,782
FAN: 2662782 		D: 2024-10-21
FD: 2024-10-21 		1 investors
17 RT: Registered Direct Offering and Concurrent Private Placement
T: -
FT: Registered Direct Offering and Concurrent Private Placement 		A: 2662782
MR: -
FA: $2,662,782
FAN: 2662782 		D: 2024-10-18
FD: 2024-10-18 		1 investors
18 RT: Registered Direct Offering and Concurrent Private Placement with Warrant Inducement
T: -
FT: Registered Direct Offering and Concurrent Private Placement with Warrant Inducement 		A: 1750000
MR: -
FA: $1.75 Million
FAN: 1750000 		D: 2024-08-05
FD: 2024-08-05 		2 investors
19 RT: Registered Direct Offering and Private Placement
T: -
FT: Registered Direct Offering and Private Placement 		A: 1750000
MR: -
FA: $1.75 Million
FAN: 1750000 		D: 2024-08-05
FD: 2024-08-05 		2 investors
20 RT: Registered Direct Offering and Private Placement
T: -
FT: Registered Direct Offering and Private Placement 		A: 1750000
MR: -
FA: 1.75 Million
FAN: 1750000 		D: 2024-08-02
FD: 2024-08-02 		3 investors
21 RT: Registered Direct Offering and Concurrent Private Placement
T: -
FT: Registered Direct Offering and Concurrent Private Placement 		A: 2500000
MR: -
FA: $2.5 Million
FAN: 2500000 		D: 2024-03-08
FD: 2024-03-08 		1 investors
22 RT: Registered Direct Offering and Private Placement
T: -
FT: Registered Direct Offering and Private Placement 		A: 2500000
MR: -
FA: $2.5 million
FAN: 2500000 		D: 2024-03-08
FD: 2024-03-08 		1 investors
23 RT: Registered Direct Offering and Concurrent Private Placement
T: -
FT: Registered Direct Offering and Concurrent Private Placement 		A: 2500000
MR: -
FA: $2,500,000
FAN: 2500000 		D: 2024-03-06
FD: 2024-03-06 		1 investors
Registered Direct Offering Latest
2025-10-09
$1.8M
1 investor (Pro only)
Registered Direct Offering 2025-10-08
$1.8M
Public Offering 2025-09-30
$4.8M

View 22 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Maria Zannes

President and Chief Executive Officer

J

J. Michael Edwards

Chief Financial Officer

W

William Bauta

Chief Science Officer

G

Gordon Downie

Chief Medical Officer

X

Xavier T. Reveles

Chief Operating Officer

D

Dallas J. Coleman

Vice President of Sales

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

bioAffinity Technologies Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare/Biotechnology
Company Size
~460 employees (est.)
Locations
San Antonio, Texas

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro